According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is ₹2.817 Trillion. In 2022 the company made a revenue of ₹2.817 Trillion an increase over the revenue in the year 2021 that were of ₹2.631 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.